Abiopharma

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Celcuity to Hold Conference Call to Discuss Results for the PIK3CA Mutant Cohort of the Phase 3 VIKTORIA-1 Clinical Trial of Gedatolisib Regimens in HR+/HER- Advanced Breast Cancer on June 2, 2026

Quantum Computing Inc. Announces Attendance at Upcoming Investor Conferences

NYSE: MMA Investor and Strategic Advisor Conor McGregor’s UFC Return Sparks Ticket Frenzy Ahead of July 11 in Las Vegas

U.S. Army Testing Shows Iperionx Titanium Fasteners Exceed Grade 8 Steel Torque-To-Yield Performance

Servier to Acquire Edgewise Therapeutics Muscular Dystrophy Business USA - English USA - English USA - Français

Sidus Space Expected Russell Index Inclusion Reflects Continued Execution of Growth and Commercialization Strategy

Turn Therapeutics Reports Interim Analysis Findings and Adaptive Optimization Strategy from Phase 2 GX-03 Trial in Moderate-to-Severe Atopic Dermatitis

SOLAI Announces Agreement to Acquire 51% Stake in NEURALAND

Fate Therapeutics Showcases Clinical Data for FT836 at the American Society of Cancer Oncology Annual Meeting